Cost of the typhoid conjugate vaccine introduction through an integrated campaign and follow-on routine immunization in Malawi.

ABSTRACT: Malawi introduced typhoid conjugate vaccine (TCV) in 2023 through an integrated campaign delivering TCV alongside other vaccines and interventions (measles rubella vaccine (MRV), bivalent oral polio vaccine (OPV), and vitamin A Supplementation). The campaign sought to reach all children 9 months to younger than 14 years, representing more than 9 million individuals, and about half the country's population. Following the campaign, TCV was incorporated into the routine immunization program for 9-month-old infants. We conducted a micro-costing study at 50 randomly selected health facilities, 10 districts, and at national level to retrospectively assess the financial and economic cost of the integrated campaign, as well as prospectively estimate the cost of delivering TCV in the routine immuni

SUBMITTER: Debellut F 

PROVIDER: S-EPMC11614825 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature